Nasdaq Sln News Today

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 162,000 shares, an increase of 74.8% from the March 15th total of 92,700 shares. Based on an average trading volume of 241,700 shares, the short-interest ratio […]

Silence Therapeutics (NASDAQ:SLN – Get Free Report) and Panbela Therapeutics (NASDAQ:PBLA – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership. Earnings & Valuation This table compares Silence […]

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $23.07, but opened at $23.84. Silence Therapeutics shares last traded at $23.97, with a volume of 99,196 shares changing hands. Wall Street Analyst Weigh In Several brokerages recently issued reports […]

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report)’s stock price rose 5.3% during trading on Tuesday . The stock traded as high as $23.88 and last traded at $23.35. Approximately 80,500 shares traded hands during trading, a decline of 68% from the average daily volume of 251,028 shares. The stock had previously closed at $22.17. […]

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) shares shot up 5.3% during trading on Tuesday . The company traded as high as $23.88 and last traded at $23.35. 80,500 shares traded hands during trading, a decline of 68% from the average session volume of 251,028 shares. The stock had previously closed at $22.17. Wall […]

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the target of a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 125,100 shares, a growth of 24.0% from the July 31st total of 100,900 shares. Based on an average daily volume of 57,800 shares, […]

Chardan Capital restated their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a report released on Thursday morning, Benzinga reports. The firm currently has a $26.00 target price on the stock. Separately, Morgan Stanley restated an overweight rating and issued a $20.00 target price on shares of Silence Therapeutics in a […]

Chardan Capital reaffirmed their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note issued to investors on Thursday, Benzinga reports. They currently have a $26.00 price target on the stock. Separately, Morgan Stanley reissued an overweight rating and set a $20.00 price target on shares of Silence Therapeutics in […]

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the recipient of a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 100,900 shares, an increase of 41.3% from the July 15th total of 71,400 shares. Currently, 0.4% of the company’s shares are short sold. […]

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the target of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 100,900 shares, a growth of 41.3% from the July 15th total of 71,400 shares. Based on an average daily volume of 69,100 shares, […]